Efficacy and Safety of Thalidomide As a Pre-Medication of Chemotherapy-Induced Nausea and Vomiting (CINV) Following Highly Emetogenic Chemotherapy (HEC): A Systematic Review and Meta-Analysis

BACKGROUND: In China, thalidomide (THD) has been used to prevent chemotherapy-induced nausea and vomiting (CINV) following highly emetogenic chemotherapy (HEC); however, there is limited evidence on the efficacy and safety of THD in this setting. The aim of this study was to evaluate the efficacy, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Jiyi, Zhang, Cong, Li, Shijun, Dai, Rong, Sullivan, Mitchell A., Deng, Bin, Xu, Qiling, Wang, Jinglin, Shi, Chen, Zhang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818791/
https://www.ncbi.nlm.nih.gov/pubmed/35141156
http://dx.doi.org/10.3389/fonc.2021.818839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818791/
https://www.ncbi.nlm.nih.gov/pubmed/35141156
http://dx.doi.org/10.3389/fonc.2021.818839

Ejemplares similares